Article
The checkpointkinase 2 (CHK2) 1100delC germ line mutation is not associated with the development of squamous cell carcinoma of the head and neck (SCCHN).
Journal of negative results in biomedicine - 25 Dec 2010
Scheckenbach Kathrin, Papadopoulou Galatia, Hoffmann Thomas K, Chaker Adam, Bier Henning, Schipper Jörg, Balz Vera, Wagenmann Martin
Abstract excerpt
BACKGROUND: The checkpointkinase 2 (CHK2) is part of the highly conserved ATM-CHK2 signaling pathway, which is activated in response to DNA damage, in particular after double strand breaks which can be caused by carcinogens like smoking. After induction of downstream targets, e.g. the tumor suppressor p53, its activation leads to cell cycle arrest and apoptosis. Recently, the presence of CHK2 germ line mutations,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
